01-27212. Breast and Cervical Cancer Early Detection and Control Advisory Committee Meeting

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. Law. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following committee meeting.

Name: Breast and Cervical Cancer Early Detection and Control Advisory Committee.

Times and Dates: 1 p.m.-5 p.m., November 14, 2001; 9 a.m.-5 p.m., November 15, 2001.

Place: The Doubletree Club Hotel—Atlanta Airport, 3400 Norman Berry Road, Atlanta, Georgia 30344, Telephone: [phone].

Status: Open to the public limited only by the space available.

Purpose: This committee is charged with providing advice and guidance to the Secretary, and the Director of CDC, regarding the need for early detection and control of breast and cervical cancer and to evaluate the Department's current breast and cervical cancer early detection and control activities.

Matters to be Discussed: The discussion will primarily focus on evaluating the CDC National Breast and Cervical Cancer Early Detection Program.

Members of the public who wish to make a brief oral presentation at the meeting should contact Ms. Cecilia Nkabinde at 770-488-4880 or Ms. Regina Seider at [phone] by 4 p.m. on November 1, 2001 to have time reserved on the agenda. Each individual or group making an oral presentation will be limited to 5 minutes. The request should identify the name of the individual who will make the presentation and an outline of the issues to be addressed. At least 25 copies of the presentation and 25 copies of the visual aids used at the meeting are to be given to Ms. Nkabinde no later than the time of the presentation for distribution to the Committee and the interested public.

Contact Person for Additional Information: Ms. Cecilia Nkabinde, Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, CDC, 4770 Buford Highway, NE., M/S K-57, Atlanta, Georgia 30341-3724, telephone [phone].

The Director, Management Analysis and Services office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Dated: October 24, 2001.

John Burckhardt,

Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.